Verrica Pharmaceuticals Inc (VRCA)
1.44
-0.09
(-5.88%)
USD |
NASDAQ |
Nov 04, 16:00
1.05
-0.39
(-27.08%)
After-Hours: 20:00
Verrica Pharmaceuticals Total Liabilities (Quarterly): 65.31M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 65.31M |
| March 31, 2024 | 64.80M |
| December 31, 2023 | 61.83M |
| September 30, 2023 | 54.84M |
| June 30, 2023 | 6.801M |
| March 31, 2023 | 3.793M |
| December 31, 2022 | 4.688M |
| September 30, 2022 | 4.382M |
| June 30, 2022 | 47.10M |
| March 31, 2022 | 46.20M |
| December 31, 2021 | 47.52M |
| September 30, 2021 | 47.90M |
| June 30, 2021 | 46.87M |
| March 31, 2021 | 46.29M |
| Date | Value |
|---|---|
| December 31, 2020 | 41.17M |
| September 30, 2020 | 40.75M |
| June 30, 2020 | 38.77M |
| March 31, 2020 | 37.83M |
| December 31, 2019 | 3.409M |
| September 30, 2019 | 4.421M |
| June 30, 2019 | 4.405M |
| March 31, 2019 | 3.218M |
| December 31, 2018 | 2.477M |
| September 30, 2018 | 2.451M |
| June 30, 2018 | 3.125M |
| March 31, 2018 | 1.648M |
| December 31, 2017 | 16.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.409M
Minimum
Dec 2019
65.31M
Maximum
Jun 2024
37.38M
Average
46.20M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Elite Pharmaceuticals Inc | 29.60M |
| Eagle Pharmaceuticals Inc | 152.78M |
| TELA Bio Inc | 57.33M |
| Terns Pharmaceuticals Inc | 12.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 52.01M |
| Shareholders Equity (Quarterly) | -13.30M |
| Debt to Equity Ratio | -3.214 |
| Current Ratio | 2.360 |
| Net Debt Paydown Yield | -2.76% |